Albert Einstein College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Albert Einstein College of Medicine sits in the top decile of US sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count).

175 total trials 20 currently recruiting 121 completed early-phase tilt top decile by trial count

Albert Einstein College of Medicine: 175 sponsored US clinical trials, 20 recruiting.

Albert Einstein College of Medicine sponsors 175 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 121 completed. 17 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 5 trials.

Top-decile sponsor footprint

Albert Einstein College of Medicine ranks in the top decile of sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

121 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

175 total, page 1 of 4

RECRUITING NA

A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents

NCT06349915

RECRUITING NA

Milk for Diabetes Prevention

NCT06513026

RECRUITING NA

Online Learning Module to Advance Research Related to People With Disabilities

NCT07220837

RECRUITING

Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures

NCT07032766

RECRUITING NA

Centralized Screening Unit (CSU) at Montefiore-Einstein

NCT06284408

RECRUITING Phase 2

Bone in CKD Alkali Response (BICARb Pilot Trial)

NCT05918029

RECRUITING NA

Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color

NCT05362929

RECRUITING NA

5-Cog 2.0: A Pragmatic Clinical Trial

NCT05515224

RECRUITING NA

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

NCT05734313

RECRUITING

Cough Capture as a Portal Into the Lung

NCT05854563

RECRUITING NA

IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs

NCT05492825

RECRUITING NA

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

NCT05039554

RECRUITING NA

Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery

NCT06524895

RECRUITING NA

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

NCT05000021

RECRUITING NA

A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx

NCT04991467

RECRUITING

Intra-Operative Radiation Registry

NCT04994067

RECRUITING Phase 1

Phase I Study of Fractionated Stereotactic Radiation Therapy

NCT03726359

RECRUITING

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

NCT00556530

RECRUITING

Hematology Biobank: In Vitro Study of Blood Disorders

NCT02442011

RECRUITING

The Longevity Genes in Founder Populations Project

NCT00707694

ACTIVE NOT RECRUITING NA

ED2PrEP - Patient Focused, Low-burden Strategies for PrEP Uptake Among Emergency Departments

NCT05588193

ACTIVE NOT RECRUITING NA

CatchU: A Quantitative Multisensory Falls-Assessment Study

NCT05544760

ACTIVE NOT RECRUITING Phase 2

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

NCT04147806

NOT YET RECRUITING NA

Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment

NCT07225400

NOT YET RECRUITING NA

Improving Clinic Delivery of HIV-related Anal Health Services

NCT07464236

NOT YET RECRUITING Phase 4

Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

NCT07526948

NOT YET RECRUITING NA

CVCs Versus Midline Catheters

NCT06884176

COMPLETED NA

The Acupuncture for Pain, Opioid Use Disorder and Mood

NCT06543355

COMPLETED Phase 4

Tobacco Cessation at FDNY

NCT05997225

COMPLETED NA

Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot

NCT05546749

COMPLETED NA

e-SMART/EST HIV Telehealth Intervention

NCT05278572

COMPLETED NA

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups

NCT05211869

TERMINATED NA

LLLT Effects on Inferior Alveolar Nerve (IAN) Recovery Post-orthognathic Surgery

NCT04910074

COMPLETED NA

Virtual Reality - Chronic Pain At-Home Pilot Study

NCT05078242

COMPLETED NA

Mitigating Sexual Stigma Within Healthcare Interactions Improve Engagement of MSM in HIV Prevention

NCT04779736

COMPLETED NA

Power-Up: An Effectiveness Trial of the Diabetes Prevention Program

NCT04104243

COMPLETED NA

VR and Chronic Pain Pilot Usability Study

NCT04923568

COMPLETED NA

Developing and Pilot Testing an Opioid Tapering Protocol

NCT04257695

COMPLETED NA

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

NCT04404153

TERMINATED Phase 1

FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy

NCT04491084

COMPLETED NA

Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder

NCT04549051

TERMINATED Phase 2

Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

NCT04393454

COMPLETED Phase 2

Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and HIV-Un-infected Women

NCT03633721

COMPLETED

Does Medical Cannabis Reduce Opioid Use in Adults With Pain

NCT04308148

COMPLETED NA

Telehealth Behavioral Migraine Management

NCT03982316

COMPLETED NA

PC4PrEP: Integrating PrEP Into Primary Care

NCT03617874

COMPLETED NA

2-A-Day Study: Twice a Day Meals Study.

NCT03809299

COMPLETED NA

Clinical Decision Support for Patient Migraine Management

NCT03706794

COMPLETED NA

5-Cog Battery for Detecting Cognitive Impairment and Dementia

NCT03816644

COMPLETED NA

Peer Mentorship to Improve Outcomes in Patients on Maintenance Hemodialysis

NCT03595748

Page 1 of 4 Next →

Phase Distribution

PhaseTrial count
Phase 1 20
Phase 2 29
Phase 3 5
Phase 4 12

What is open in the Albert Einstein College of Medicine pipeline

20 recruiting of 175 indexed (11% open); 121 completed (69%).

Phase mix: 17 late (III/IV) vs 49 early (I/II) (early-phase heavy).

Top condition: Chronic Pain (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Albert Einstein College of Medicine: open-pipeline peers nationwide

Peers matched on 175 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20% Total trials Recruiting share Albert Einstein College of MedicineBausch & Lomb IncorporatedUConn HealthBaylor Research InstituteAbbottUniversity of MemphisChildren's Mercy Hospital Kansas CityJanssen Research & DevelopmentBarbara Ann Karmanos Cancer Institute
Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 175 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Albert Einstein College of Medicine page

175 registered trials is a research-attention snapshot, not an endorsement of Albert Einstein College of Medicine or any single study.

  • 20 of Albert Einstein College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic Pain is the condition Albert Einstein College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Albert Einstein College of Medicine pipeline card: 175 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.